By By Robert Preidt HealthDay Reporter, HealthDay Reporter
THURSDAY, April 14, 2022 (HealthDay News) — A person in five Medicare recipients use medical marijuana and two-thirds say it really should be lined by Medicare, a new survey reveals.
The poll of 1,250 Medicare recipients was executed in April and observed that one particular in five use clinical cannabis and 23% have utilized it in the previous. In all, 21% said they use it to deal with a single or far more healthcare problems.
Present use for health explanations was maximum amongst respondents who also used marijuana recreationally (39%). In all, 28% of leisure buyers mentioned they earlier applied health care cannabis.
Respondents use it to treat a wide range of physical and mental overall health problems, which includes 32% for nervousness and 31% for serious agony. Around one particular-quarter said they use it to deal with melancholy, glaucoma, and signs and symptoms associated with HIV/AIDS, together with nausea, urge for food loss and discomfort.
Between respondents, aid was powerful for Medicare coverage of medical cannabis.
Two-thirds claimed they “strongly agree” or “concur” that clinical cannabis need to be protected. 30-four percent stated they “disagree” or “strongly disagree.”
Approximately six in 10 supporters of Medicare coverage said they do so due to the fact health-related marijuana can be powerful when other treatments fail.
Remarkably, support for Medicare coverage was decrease amongst recent health care cannabis consumers (56%), when compared with 63% of former users and 71% of these who mentioned they’ve under no circumstances employed it.
Why the reluctance among the existing people?
Just about four in 10 (38%) claimed they fear Medicare protection would increase the drug price tag.
Pollsters identified that present users’ out-of-pocket prices have been large-ranging. 50 percent described spending up to $200 for each thirty day period 36%, amongst $201 and $500 per month and 14% far more than $500 a thirty day period.
In all, 31% of users who oppose Medicare protection of health-related cannabis cited unidentified lengthy-time period impacts and a deficiency of research into its utilizes and effectiveness.
Fifty percent of buyers said they would like medical marijuana to be lined by Medicare mainly because it can be a multipurpose treatment.
Between earlier people who assistance Medicare protection, the best purpose (48%) is that cannabis is a purely natural cure, not a synthetic pharmaceutical.
The study also uncovered dissimilarities based mostly